[Bacterial vaginosis II. Related pathology and therapy].
Oyarzún
E
E
Departamento de Obstetricia y Ginecología, Pontificia Universidad Católica de Chile.
Gómez
R
R
Montiel
F
F
D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D002821:Chorioamnionitis / Q000150:complications; D002981:Clindamycin / Q000627:therapeutic use; D004716:Endometritis / Q000150:complications; D005260:Female; D006801:Humans; D008795:Metronidazole / Q000627:therapeutic use; D007752:Obstetric Labor, Premature / Q000150:complications; D011247:Pregnancy; D011251:Pregnancy Complications, Infectious / Q000188:drug therapy; D012008:Recurrence; D012307:Risk Factors; D012488:Salpingitis / Q000150:complications; D002578:Uterine Cervical Dysplasia / Q000150:complications; D016585:Vaginosis, Bacterial / Q000150:complications / Q000188:drug therapy / Q000635:transmission
D000900:Anti-Bacterial Agents; D008795:Metronidazole; D002981:Clindamycin
Vaginosis bacteriana II. Patología relacionada y tratamiento.